<DOC>
	<DOCNO>NCT00482729</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety investigational treatment type 2 diabetes mellitus .</brief_summary>
	<brief_title>MK0431A Comparative Study Patients With Type 2 Diabetes ( 0431A-079 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patient type 2 diabetes mellitus Patient great equal 18 less equal 78 year age day sign consent Patient Hb1Ac great equal 7.5 % appropriate oral therapy Patient antihyperglycemic agent ( AHA ) last 4 month Patient male , female unlikely conceive Patient type 1 diabetes mellitus history ketoacidosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>